GO:0001784 phosphotyrosine residue binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001784 phosphotyrosine residue binding is a molecular function defined as binding to a phosphorylated tyrosine residue within a protein, and it is the core recognition event for SH2 and PTB domain-containing signaling proteins.
• SH2 domains recognize phosphotyrosine peptides through a conserved pocket, and engineering this pocket can produce superbinders with altered affinity and specificity.
• The function is not limited to canonical SH2/PTB modules; pyruvate kinase M2 (PKM2) was identified as a phosphotyrosine-binding protein, linking this activity to metabolic regulation.
• Phosphotyrosine mimetics and chemical probes, including pentafluorophosphato-phenylalanines, are used to interrogate and manipulate phosphotyrosine-dependent interactions.
• Proximal crosslinking and superresolution imaging methods such as Protein-PAINT enable mapping and visualization of phosphotyrosine peptide-SH2 domain interactions in cells.
• Dysregulated phosphotyrosine residue binding underlies cancer, immune signaling disorders, and other diseases, making it a major target for CRISPR-based functional studies.
Description
Phosphotyrosine residue binding (GO:0001784) is a molecular function that enables a protein to selectively recognize and bind a phosphorylated tyrosine residue within another protein. This activity is fundamental to cellular signal transduction because tyrosine phosphorylation acts as a reversible switch that creates docking sites for downstream effectors. The function is best known for its role in SH2 and PTB domain-mediated interactions, where a conserved pocket engages the phosphotyrosine moiety with high specificity. Researchers study this term to understand how signals propagate from receptor tyrosine kinases to cytoplasmic pathways, and how mutations or dysregulation contribute to diseases such as cancer. Beyond classical signaling modules, phosphotyrosine-binding activity has been identified in unexpected proteins such as pyruvate kinase M2, expanding its functional repertoire. The availability of chemical mimetics and advanced imaging tools now allows precise interrogation of these interactions in living cells.
phosphotyrosine residue binding At A Glance
| GO ID | GO:0001784 |
|---|---|
| GO term | phosphotyrosine residue binding |
| Ontology | molecular_function |
| Synonym | phosphotyrosine binding |
| Definition | Binding to a phosphorylated tyrosine residue within a protein. |
| Major function | Recognition of phosphotyrosine-containing motifs to assemble signaling complexes and propagate cellular signals. |
| Representative domains | SH2 domains, PTB domains, and other phosphotyrosine-recognition modules. |
| Related activity | Protein tyrosine kinase signaling and phosphotyrosine-dependent protein-protein interactions. |
What Is GO:0001784?
According to the Gene Ontology, GO:0001784 phosphotyrosine residue binding is defined as the binding to a phosphorylated tyrosine residue within a protein. In practice, this means a protein domain or surface recognizes a tyrosine side chain that carries a phosphate group, typically in the context of a short peptide motif, and forms non-covalent interactions that confer specificity and affinity. This function is distinct from tyrosine kinase activity because it does not catalyze phosphate transfer; instead, it mediates protein-protein association and signal complex assembly.
Why Is phosphotyrosine residue binding Important in Cell Biology?
Phosphotyrosine residue binding is a central mechanism by which cells convert tyrosine phosphorylation events into specific biological outcomes, including proliferation, differentiation, migration, and immune responses. Because many oncogenic mutations and disease-associated variants alter tyrosine kinase signaling, understanding this binding function is critical for target identification and therapeutic development. The function also provides a paradigm for studying protein interaction specificity, as subtle changes in the binding pocket can rewire signaling networks.
• It enables SH2 and PTB domain proteins to dock onto activated receptor tyrosine kinases and initiate downstream signaling.
• It is essential for immune cell activation, cytokine signaling, and growth factor responses.
• Dysregulated phosphotyrosine binding contributes to cancer, autoimmune diseases, and developmental disorders.
• It provides a target for chemical probes and phosphotyrosine mimetics that can modulate signaling.
• It is a key parameter in engineering synthetic signaling circuits and biosensors.
• It links tyrosine phosphorylation to metabolic regulation through non-canonical phosphotyrosine-binding proteins such as PKM2.
• It is a focus of structural and computational studies aimed at predicting and designing phosphopeptide-binding specificity.
• It is relevant to drug discovery because blocking or enhancing specific phosphotyrosine interactions can alter disease phenotypes.
Molecular Mechanism of phosphotyrosine residue binding
Recognition of the phosphotyrosine moiety
In simple terms: The binding protein has a pocket that fits the phosphate group on tyrosine, like a lock for a key.
The defining event in GO:0001784 is the direct binding of a protein surface to a phosphorylated tyrosine residue. Structural studies of SH2 domains show that a conserved arginine and other pocket residues coordinate the phosphate group, while surrounding residues provide specificity for the peptide context. The binding is non-covalent and reversible, allowing dynamic assembly and disassembly of signaling complexes.
Domain architecture and specificity
In simple terms: Different proteins use different modules, such as SH2 or PTB domains, to read the phosphotyrosine code.
SH2 domains are the archetypal phosphotyrosine-binding modules, but PTB domains and other folds also mediate this function. The SHC PTB domain, for example, requires specific residues for phosphopeptide interaction, and mutations in these residues abolish binding. Specificity is determined by both the phosphotyrosine itself and the flanking amino acids, which are read by variable loops on the domain surface.
Non-canonical phosphotyrosine-binding proteins
In simple terms: Some proteins that are not classic signaling modules can also bind phosphotyrosine, linking this function to unexpected processes.
Pyruvate kinase M2 (PKM2) was identified as a phosphotyrosine-binding protein, demonstrating that this molecular function extends beyond SH2 and PTB domains. This finding connects phosphotyrosine binding to metabolic regulation and suggests that other metabolic enzymes may harbor similar activities.
Chemical mimetics and probes
In simple terms: Scientists have made artificial molecules that mimic phosphotyrosine to study or block these interactions.
Pentafluorophosphato-phenylalanines are amphiphilic phosphotyrosine mimetics that display fluorine-specific protein interactions, providing tools to probe and potentially inhibit phosphotyrosine-dependent binding. Such mimetics can be incorporated into peptides or proteins to interrogate the function in vitro and in cells.
Detection and visualization methods
In simple terms: Researchers use crosslinking and superresolution imaging to see where and when phosphotyrosine binding happens.
Proximal crosslinking with phosphotyrosine peptides and SH2 domains allows mapping of binding interactions in vitro. Protein-PAINT, a superresolution microscopy approach using signaling proteins, enables visualization of phosphotyrosine-dependent complexes with high spatial resolution in cells.
Key Genes Involved in GO:0001784 phosphotyrosine residue binding
The following genes encode proteins that directly mediate or regulate phosphotyrosine residue binding (GO:0001784), based on published biochemical and structural evidence.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SHC1 | Contains a PTB domain that binds phosphotyrosine motifs on activated receptors. | Model for studying PTB domain specificity and downstream MAPK activation. |
| FYN | SH2 domain binds phosphotyrosine peptides; engineered superbinders alter affinity. | Used to dissect SH2 domain binding energetics and signaling. |
| SRC | SH2 domain mediates phosphotyrosine-dependent interactions in signaling. | Prototype for SH2 domain structure-function studies. |
| PIK3R1 | SH2 domains bind phosphotyrosine motifs on receptor tyrosine kinases. | Key node in PI3K/AKT signaling and cancer research. |
| GRB2 | SH2 domain binds phosphotyrosine motifs to link receptors to RAS signaling. | Common model for SH2 domain binding and inhibitor development. |
| STAT1 | SH2 domain mediates phosphotyrosine-dependent dimerization and signaling. | Studied in cytokine signaling and serine phosphorylation crosstalk. |
| STAT3 | SH2 domain binds phosphotyrosine to drive transcriptional activation. | Target in cancer and inflammation research. |
| PKM2 | Non-canonical phosphotyrosine-binding protein affecting metabolism. | Links phosphotyrosine binding to cancer metabolism. |
| PTPN11 | Contains SH2 domains that bind phosphotyrosine and regulate signaling. | Relevant to developmental disorders and leukemia. |
| CRK | SH2 domain binds phosphotyrosine motifs in adhesion and migration. | Model for studying cytoskeletal signaling. |
| NCK1 | SH2 domain mediates phosphotyrosine-dependent actin regulation. | Used in studies of cell motility. |
| VAV1 | SH2 domain binds phosphotyrosine to activate immune signaling. | Important in lymphocyte activation research. |
| SYK | SH2 domains bind phosphotyrosine motifs on immune receptors. | Target for autoimmune and allergy studies. |
| ZAP70 | SH2 domains bind phosphotyrosine in T cell receptor signaling. | Model for T cell activation. |
| PLCG1 | SH2 domain binds phosphotyrosine to trigger calcium signaling. | Studied in receptor tyrosine kinase pathways. |
| ABL1 | SH2 domain binds phosphotyrosine and regulates kinase activity. | Relevant to leukemia and targeted therapy. |
How Is phosphotyrosine residue binding Regulated?
The phosphotyrosine residue binding function is regulated by the balance of tyrosine kinase and phosphatase activities that determine the presence and lifetime of the phosphotyrosine mark. Serine phosphorylation of STAT proteins can modulate their SH2 domain-mediated phosphotyrosine binding and dimerization, illustrating crosstalk between different phosphorylation events. Additionally, the expression levels and post-translational modifications of SH2 or PTB domain-containing proteins can influence binding capacity. Chemical mimetics and engineered superbinders can also be used to experimentally modulate this function.
phosphotyrosine residue binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GRB2 | Cancer (RAS/MAPK pathway activation) | Knockout or point-mutation cell lines to disrupt SH2 binding |
| PIK3R1 | Cancer and immune dysregulation | Knock-in of patient-derived SH2 mutations |
| PKM2 | Cancer metabolism | Overexpression and phosphotyrosine-binding mutant models |
| STAT3 | Cancer and inflammation | Point mutation of SH2 domain to block phosphotyrosine binding |
| PTPN11 | Developmental disorders and leukemia | Knock-in of disease-associated SH2 mutations |
Cancer
Many oncogenic signaling pathways depend on phosphotyrosine residue binding by SH2 and PTB domain proteins. For example, GRB2 and PIK3R1 SH2 domains couple activated receptor tyrosine kinases to RAS and PI3K pathways, and mutations that alter these interactions can drive tumorigenesis. PKM2, a non-canonical phosphotyrosine-binding protein, is highly expressed in cancer cells and links this function to metabolic reprogramming.
Immune and inflammatory disorders
Phosphotyrosine binding by SH2 domains in SYK, ZAP70, and STAT proteins is essential for immune receptor signaling. Dysregulation of these interactions can lead to autoimmunity, immunodeficiency, or chronic inflammation.
Developmental and metabolic diseases
PTPN11 (SHP2) SH2 domain mutations affect phosphotyrosine binding and cause developmental syndromes and leukemias. The discovery of PKM2 as a phosphotyrosine-binding protein suggests broader links to metabolic disorders.
From phosphotyrosine residue binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a phosphotyrosine-binding domain affect downstream signaling? | Knockout cell line lacking the domain-containing gene |
| Does a specific point mutation abolish phosphotyrosine binding? | Point-mutation knock-in of the binding pocket residue |
| Can a disease-associated mutation alter binding specificity? | Knock-in of patient variant followed by phosphopeptide binding assay |
| Where does phosphotyrosine binding occur in cells? | Tagged knock-in with fluorescent protein for imaging |
| Can overexpression of a phosphotyrosine-binding protein drive transformation? | Overexpression cell model |
| What is the affinity of a designed superbinding domain? | Engineered SH2 domain variants expressed in cells |
How to Study the phosphotyrosine residue binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Proximal crosslinking | Direct binding between phosphotyrosine peptides and SH2 domains | Mapping interaction interfaces |
| Protein-PAINT | Spatial distribution of signaling complexes | Superresolution imaging of phosphotyrosine-dependent clusters |
| Isothermal titration calorimetry | Binding affinity and thermodynamics | Quantifying SH2 domain-phosphopeptide interactions |
| X-ray crystallography | Atomic structure of binding pocket | Understanding specificity determinants |
| Phage display | Peptide binding specificity | Engineering superbinders |
| Fluorescence polarization | Binding affinity in solution | Screening phosphotyrosine mimetics |
| CRISPR knockout | Loss-of-function phenotype | Testing requirement of binding protein in signaling |
Proximal crosslinking and binding assays
Proximal crosslinking between phosphotyrosine peptides and SH2 domains allows covalent capture of transient interactions, enabling mapping of binding interfaces. This method is useful for identifying direct binding partners and for validating specificity.
Superresolution imaging
Protein-PAINT uses signaling proteins to achieve superresolution microscopy, allowing visualization of phosphotyrosine-dependent complexes at the nanoscale. This approach can reveal spatial organization of signaling clusters in cells.
Structural and computational analysis
Structural studies of SH2 domains and their phosphopeptide complexes provide atomic-level insights into binding mechanisms. Computational design and mutagenesis can generate superbinders with altered specificity, as demonstrated for the Fyn SH2 domain.
Chemical biology and mimetics
Phosphotyrosine mimetics such as pentafluorophosphato-phenylalanines can be incorporated into peptides to probe or disrupt binding interactions. These tools complement genetic approaches for studying GO:0001784.
How CRISPR Can Be Used to Study GO:0001784 phosphotyrosine residue binding
Knockout
CRISPR knockout of genes encoding phosphotyrosine-binding proteins, such as SHC1 or GRB2, can abolish specific signaling outputs and reveal the functional importance of GO:0001784 in a given pathway. Knockout cell lines are useful for epistasis experiments and for validating drug targets.
Point Mutation
Point mutations in the phosphotyrosine-binding pocket, such as those in the SHC PTB domain, can selectively disable binding without affecting protein expression. CRISPR-mediated point mutation knock-in allows precise testing of binding residues in the native genomic context.
Knock-in
Knock-in of disease-associated mutations or engineered superbinders can model altered phosphotyrosine binding and its downstream consequences. Tagged knock-in with fluorescent or affinity tags enables imaging and proteomic analysis of binding complexes.
Overexpression
Overexpression of wild-type or mutant phosphotyrosine-binding proteins can drive signaling activation or dominant-negative effects, providing a complementary approach to loss-of-function studies. This is particularly useful for non-canonical binders such as PKM2.
How EDITGENE Supports phosphotyrosine residue binding Research
Researchers studying phosphotyrosine residue binding-related genes often need to determine whether a candidate gene is causally involved in a specific signaling or disease phenotype. EDITGENE provides CRISPR-based cell model services to enable precise genetic manipulation of these genes, from complete knockout to subtle point mutations, supporting functional validation and drug target discovery.
Contact EDITGENE today to design your custom CRISPR model for phosphotyrosine residue binding research.
Frequently Asked Questions About phosphotyrosine residue binding
What is phosphotyrosine residue binding?
Phosphotyrosine residue binding (GO:0001784) is a molecular function defined as binding to a phosphorylated tyrosine residue within a protein, typically mediated by SH2 or PTB domains.
What genes are involved in phosphotyrosine residue binding?
Genes encoding SH2 and PTB domain proteins include SHC1, GRB2, PIK3R1, SRC, FYN, STAT1, STAT3, and PTPN11, among others.
What is the GO ID for phosphotyrosine residue binding?
The Gene Ontology ID is GO:0001784, with the synonym phosphotyrosine binding.
How is phosphotyrosine residue binding studied?
Common methods include proximal crosslinking, superresolution imaging, isothermal titration calorimetry, X-ray crystallography, and CRISPR-based genetic screens.
Which domains mediate phosphotyrosine residue binding?
SH2 domains are the most common, but PTB domains and other folds also mediate this function.
Is PKM2 a phosphotyrosine-binding protein?
Yes, pyruvate kinase M2 (PKM2) was identified as a phosphotyrosine-binding protein, linking this function to metabolism.
What diseases are associated with defective phosphotyrosine binding?
Cancer, immune disorders, and developmental syndromes can result from mutations affecting phosphotyrosine-binding proteins such as GRB2, PIK3R1, and PTPN11.
Can phosphotyrosine binding be inhibited by drugs?
Phosphotyrosine mimetics and engineered superbinders can modulate these interactions, and they are being explored as chemical tools and potential therapeutics.
What is the role of SH2 domains in phosphotyrosine binding?
SH2 domains contain a conserved pocket that specifically recognizes phosphotyrosine and couples activated receptors to downstream signaling.
How can CRISPR help study phosphotyrosine residue binding?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes encoding phosphotyrosine-binding proteins to test their function in cells.
Conclusion
GO:0001784 phosphotyrosine residue binding is a fundamental molecular function that underpins tyrosine phosphorylation-dependent signal transduction. Its study has revealed canonical SH2 and PTB domain mechanisms, non-canonical examples like PKM2, and a growing toolbox of chemical and imaging methods. Understanding this function is essential for dissecting normal physiology and for developing therapies against cancer, immune disorders, and other diseases driven by aberrant phosphotyrosine signaling.
References
- 1. Wang R et al.. 2023. Exploring the Binding Interaction Between Phosphotyrosine Peptides and SH2 Domains by Proximal Crosslinking.. Methods Mol Biol 2705:255-267 PMID: 37668979
- 2. Farrell MV et al.. 2022. Protein-PAINT: Superresolution microscopy with signaling proteins.. Sci Signal 15(719):eabg9782 PMID: 35104163
- 3. Bradshaw JM et al.. 2002. Molecular recognition by SH2 domains.. Adv Protein Chem 61:161-210 PMID: 12461824
- 4. Christofk HR et al.. 2008. Pyruvate kinase M2 is a phosphotyrosine-binding protein.. Nature 452(7184):181-6 PMID: 18337815
- 5. Decker T et al.. 2000. Serine phosphorylation of STATs.. Oncogene 19(21):2628-37 PMID: 10851062
- 6. Li S et al.. 2021. Revisiting the phosphotyrosine binding pocket of Fyn SH2 domain led to the identification of novel SH2 superbinders.. Protein Sci 30(3):558-570 PMID: 33314411
- 7. Accorsi M et al.. 2022. Pentafluorophosphato-Phenylalanines: Amphiphilic Phosphotyrosine Mimetics Displaying Fluorine-Specific Protein Interactions.. Angew Chem Int Ed Engl 61(25):e202203579 PMID: 35303375
- 8. Yajnik V et al.. 1996. Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction.. J Biol Chem 271(4):1813-6 PMID: 8567619
